X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11960) 11960
Publication (1501) 1501
Book Review (141) 141
Newsletter (130) 130
Newspaper Article (74) 74
Magazine Article (46) 46
Book Chapter (29) 29
Conference Proceeding (10) 10
Trade Publication Article (8) 8
Book / eBook (5) 5
Dissertation (4) 4
Data Set (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7760) 7760
reverse transcriptase polymerase chain reaction (5954) 5954
index medicus (5837) 5837
animals (5397) 5397
male (4879) 4879
female (4162) 4162
hiv infections - drug therapy (2891) 2891
mice (2847) 2847
adult (2306) 2306
blotting, western (2060) 2060
reverse transcriptase inhibitors - administration & dosage (2035) 2035
reverse transcriptase inhibitors - therapeutic use (1946) 1946
rats (1923) 1923
research (1843) 1843
infectious diseases (1809) 1809
pharmacology & pharmacy (1771) 1771
middle aged (1643) 1643
gene expression (1586) 1586
hiv (1515) 1515
immunology (1496) 1496
anti-hiv agents - administration & dosage (1495) 1495
drug therapy, combination (1434) 1434
expression (1404) 1404
anti-hiv agents - therapeutic use (1389) 1389
research article (1373) 1373
rna, messenger - genetics (1287) 1287
oncology (1215) 1215
medicine (1162) 1162
health aspects (1138) 1138
drug therapy (1130) 1130
apoptosis (1090) 1090
immunohistochemistry (1085) 1085
multidisciplinary sciences (1072) 1072
virology (1060) 1060
hiv infections - virology (1052) 1052
cells, cultured (1040) 1040
hiv-1 - drug effects (1027) 1027
proteins (1018) 1018
rna, messenger - metabolism (992) 992
science (972) 972
treatment outcome (947) 947
rodents (936) 936
antiviral agents (931) 931
physiological aspects (925) 925
mice, inbred c57bl (901) 901
antiretroviral therapy (896) 896
viral load (888) 888
cancer (858) 858
genetic aspects (846) 846
cell line, tumor (839) 839
reverse transcriptase inhibitors - adverse effects (837) 837
mutation (815) 815
care and treatment (814) 814
time factors (813) 813
rats, sprague-dawley (805) 805
analysis (804) 804
dose-response relationship, drug (802) 802
cell biology (782) 782
dosage and administration (782) 782
human immunodeficiency virus--hiv (775) 775
therapy (774) 774
hiv infection (758) 758
cells (750) 750
drug administration schedule (746) 746
microbiology (745) 745
biochemistry & molecular biology (737) 737
endocrinology & metabolism (718) 718
gene-expression (701) 701
article (693) 693
in-vitro (689) 689
aids (681) 681
anti-hiv agents - adverse effects (675) 675
biology (675) 675
reverse-transcriptase inhibitors (671) 671
antiretroviral drugs (662) 662
inflammation (658) 658
aged (651) 651
physiology (649) 649
disease models, animal (646) 646
cd4 lymphocyte count (639) 639
activation (637) 637
flow cytometry (625) 625
protease inhibitors (623) 623
reverse transcriptase inhibitors (621) 621
polymerase chain reaction (617) 617
cell line (613) 613
risk factors (611) 611
real-time polymerase chain reaction (610) 610
hiv protease inhibitors - administration & dosage (606) 606
human-immunodeficiency-virus (592) 592
apoptosis - drug effects (589) 589
signal transduction (589) 589
tenofovir (587) 587
infection (576) 576
lamivudine - administration & dosage (575) 575
hiv protease inhibitors - therapeutic use (566) 566
hiv-1 - genetics (566) 566
medicine, research & experimental (565) 565
drug resistance (558) 558
enzyme-linked immunosorbent assay (551) 551
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12000) 12000
Spanish (68) 68
Chinese (40) 40
German (38) 38
French (31) 31
Japanese (20) 20
Italian (11) 11
Russian (11) 11
Polish (10) 10
Dutch (5) 5
Danish (2) 2
Hungarian (2) 2
Korean (2) 2
Norwegian (2) 2
Hebrew (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HIV Medicine, ISSN 1464-2662, 11/2008, Volume 9, Issue 10, pp. 883 - 896
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1145 - 1155
Journal Article
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9553, pp. 2125 - 2135
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 22, pp. 2121 - 2132
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1752 - 1759
Background. To our knowledge, to date, no prospective, randomized, clinical trial has compared standard doses of efavirenz-and nevirapine-based antiretroviral... 
HIV/AIDS | Medical treatment failures | Antiretrovirals | Tuberculosis | Infectious diseases | RNA | AIDS | Infections | HIV 1 | Arts | Virology | INDIVIDUALS | SURVIVAL | MORTALITY | INFECTIOUS DISEASES | TUBERCULOSIS | ADULTS | MICROBIOLOGY | EFAVIRENZ 600 MG/DAY | ANTIRETROVIRAL THERAPY | OUTCOMES | IMMUNOLOGY | NEVIRAPINE LEVELS | Prospective Studies | Humans | Middle Aged | Male | Nevirapine - therapeutic use | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Anti-HIV Agents - administration & dosage | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Benzoxazines - pharmacokinetics | HIV-1 - isolation & purification | Tuberculosis - drug therapy | Adult | Anti-HIV Agents - therapeutic use | Female | Rifampin - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Benzoxazines - administration & dosage | Treatment Outcome | CD4 Lymphocyte Count | Benzoxazines - therapeutic use | Antiretroviral Therapy, Highly Active | Anti-HIV Agents - pharmacokinetics | Plasma - chemistry | HIV Infections - complications | HIV Infections - drug therapy | Nevirapine - administration & dosage | Nevirapine - pharmacokinetics | Antiviral agents | Usage | Patient outcomes | Reverse transcriptase inhibitors | Dosage and administration | Comparative analysis | Drug therapy | Rifampin | Health aspects | HIV infection |